Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Kevin Young CBEThe Department of Pharmacology is delighted to announce that Kevin Young CBE has made a sizable donation to the Department. Professor Frances Platt FRS FMedSci said, “This is one of the largest donations in the hundred-year history of the Department and we were also delighted that Mr Young joined our community as a Senior Research Fellow last year. His insight and experience in drug discovery will be greatly valued by the Department and the Medical Sciences Division.”

Kevin has worked for over 35 years in Biopharma, including ICI Pharmaceuticals, Amgen and Gilead. He retired in February 2018 as Chief Operating Officer with Gilead Sciences. During his tenure, Gilead transformed the treatment of multiple viral diseases, notably HIV, Hepatitis B, Hepatitis C and Influenza.

Kevin has degrees in Sports Science and Exercise and has 18 publications in human muscle physiology to his name. Originally from York, England, Kevin resides on the West Coast of the USA.

In 2011, Kevin was appointed ‘Commander of The Most Excellent Order of the British Empire’ in recognition of his contributions to the Biopharma Industry and Healthcare.

We are extremely grateful for his most generous gift and his membership of our community in Oxford.

Similar stories

Consequences of Tau pathology on hippocampal pyramidal neurons and network activity in ageing mice

Pathological hyperphosphorylated forms of the microtubule-associated binding protein Tau (pTau) are commonly found in people with neurodegenerative diseases, including Alzheimer’s disease, Corticobasal degeneration, and Progressive supranuclear palsy.

Welcome to the 2022/23 academic year in Pharmacology!

At the start of this year, we have welcomed 23 new MSc in Pharmacology students, 13 new MSc(Res) and DPhil students and around a dozen additional project and visiting students from other Departments and other Universities. Some of these new starters joined existing staff, students and visitors in the Department for the first of a series of group photographs, to be taken every 6 months for our archives.

New Platt group paper explores links between Mycobacteria tuberculosis and Niemann-Pick Type C disease

Congratulations to Yuzhe Weng, a DPhil student in the Platt lab, who is first author on new paper published by the group in Nature Communications. Mycobacteria tuberculosis (Mtb), the causative agent of tuberculosis (TB), has the ability to invade, persist and replicate within host cells, which is key to its success as a pathogen. However, the mechanisms that underlie this strategy remain poorly defined.


We were sad to learn that our dear colleague Rebecca has died just a few days before what would have been her 63rd birthday.

New high-resolution imaging provides clue to SARS-CoV-2 leap to humans

A new paper, published this week in the journal Science, highlights cutting-edge imaging techniques used by the group of Professor Ben Davis to investigate the binding of SARS-CoV-2 to human cells.

Dr Mehmood Khan joins Pharmacology as a Visiting Fellow

We are delighted to announce the appointment of Dr Mehmood Khan as a Visiting Fellow in the Department